Combined Methylphenidate and Fluoxetine or Cocaine Exposure during Adolescence Alters ERK2-Related Signaling in the VTA and Increase Sensitivity to Nicotine Reward in Adulthood

Combined Methylphenidate and Fluoxetine or Cocaine Exposure during Adolescence Alters ERK2-Related Signaling in the VTA and Increase Sensitivity to Nicotine Reward in Adulthood

The most common treatment strategy for adolescents with attention deficit/hyperactivity disorder (ADHD) and major depressive disorder (MDD) is combined methylphenidate (MPH) and fluoxetine (FLX). This has raised concerns because combined MPH+FLX treatment may have pharmacodynamic properties similar...

Full description

Bibliographic Details
Other Authors: Alcantara, Lyonna F. (authoraut)
Format: Others
Language:English
English
Published: Florida State University
Subjects:
Psychology
Neurosciences
Online Access:http://purl.flvc.org/fsu/fd/FSU_migr_etd-7687

Internet

http://purl.flvc.org/fsu/fd/FSU_migr_etd-7687

Similar Items